United States · Seed startup

Who invested in Genesis Therapeutics

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$4.1Mraised across 1 round since 2019, from 1 source

Latest round
Seed, $4.1MNov 2019
Led by
Andreessen Horowitz
Investors
2 (1 led)
See who backed them

The rounds

  1. Nov 2019
    Seed$4.1M

    Reported by FinSMEs

Founders and team

From Genesis Therapeutics's own website and the SEC filings it signed: 1 founder, 7 on the team.

Evan Feinberg Ph.D.CEO, Co-founder
  • Sergey EdunovCTO
  • Shifeng Pan Ph.D.COO
  • Will McCarthyCOO
  • Benjamin SklaroffExecutive Officeri
  • Evan FeinbergExecutive Officer, Directori
  • Peptiboon PrasitExecutive Officer, Directori
  • William MccarthyExecutive Officeri

On the board, as filediKris JennerLeonard BellVijay Pande

Everyone who backed them

Andreessen HorowitzVC firm1round, led 1
FelicisVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list Genesis Therapeutics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Ulu VenturesVC firmPer its own site
Open Field CapitalVC firmPer its own site
JCJ CapitalVC firmPer its own site

Quick answers about Genesis Therapeutics

Who invested in Genesis Therapeutics?

Genesis Therapeutics's investors include Andreessen Horowitz and Felicis. Andreessen Horowitz led its latest round.

How much has Genesis Therapeutics raised?

Genesis Therapeutics has raised $4.1M across 1 round since 2019.

When did Genesis Therapeutics last raise?

Genesis Therapeutics's most recent round was a Seed of $4.1M in Nov 2019, led by Andreessen Horowitz.

What was Genesis Therapeutics's biggest round?

Its most recent round, $4.1M in Nov 2019, is also its largest on record.

Who backed Genesis Therapeutics first?

Genesis Therapeutics's first round on record, in Nov 2019, was backed by Andreessen Horowitz and Felicis.

What stage is Genesis Therapeutics at?

Genesis Therapeutics's latest named round is a Seed, in Nov 2019.

Where is Genesis Therapeutics based?

Genesis Therapeutics is based in the United States.

Who led Genesis Therapeutics's rounds?

Andreessen Horowitz led the Seed in 2019.

Companies like Genesis Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.